EDAP TMS(us:EDAP)
1.96
0.00%
Updated on 2025-04-02
Open:2.01
Close:1.96
High:2.35
Low:1.90
Prev Close:1.96
Volume:209847.00
Turnover:418043.66
Turnover Ratio:0.56%
Shares:37.39M
MarketCap:73.29M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 39 | 15940660 | 42.96% | 2 | 7 | 16 |
| 2024-03-31 | 40 | 16195941 | 43.65% | 7 | 8 | 11 |
| 2023-12-31 | 41 | 15919408 | 42.91% | 1 | 9 | 20 |
| 2023-09-30 | 56 | 15855460 | 42.94% | 4 | 11 | 33 |
| 2023-06-30 | 60 | 16041700 | 43.44% | 9 | 23 | 19 |
| 2023-03-31 | 58 | 14810597 | 40.11% | 8 | 22 | 14 |
| 2022-12-31 | 53 | 14093259 | 38.18% | 20 | 10 | 10 |
| 2022-09-30 | 39 | 12738796 | 35.24% | 8 | 8 | 9 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Soleus Capital Management, L.P. | 7227353 | 19.48% | 1012 | 0.01% |
| 2024-03-31 | Morgan Stanley | 3373888 | 9.09% | -8594 | -0.25% |
| 2024-03-31 | Rock Springs Capital Management Lp | 1475000 | 3.98% | 88575 | 6.39% |
| 2024-03-31 | Archon Capital Management Llc | 1208308 | 3.26% | 0 | |
| 2024-03-31 | Federated Hermes, Inc. | 809135 | 2.18% | -71736 | -8.14% |
| 2024-03-31 | Bruce & Co., Inc. | 553652 | 1.49% | 0 | |
| 2024-03-31 | Apis Capital Advisors, Llc | 545976 | 1.47% | 9876 | 1.84% |
| 2024-03-31 | Cahill Financial Advisors Inc | 134960 | 0.36% | 0 | |
| 2024-03-31 | Ubs Group Ag | 98800 | 0.27% | 94026 | 1969.54% |
| 2024-03-31 | Susquehanna International Group, Llp | 93927 | 0.25% | 40731 | 76.57% |
About
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.
Address:Parc d'Activités la Poudrette-Lamart,4/6, rue du Dauphine
Website:http://www.edap-tms.com
Market Movers